89bio
ETNB
ETNB
150 hedge funds and large institutions have $1.14B invested in 89bio in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 52 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
150
Holders Change
-3
Holders Change %
-1.96%
% of All Funds
2.17%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
22
Increased
69
Reduced
52
Closed
25
Calls
$9.08M
Puts
$15.3M
Net Calls
-$6.22M
Net Calls Change
+$1.67M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$42.9M |
| 2 |
RI
RTW Investments
New York
|
+$20.9M |
| 3 |
SCM
Suvretta Capital Management
New York
|
+$16.4M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.7M |
| 5 |
BlackRock
New York
|
+$13.8M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$31.1M |
| 2 |
Morgan Stanley
New York
|
-$25.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$21.9M |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$11.6M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$9.86M |
